CT与B超在诊断妇科盆腔肿瘤中的应用价值对比

目的对比分析CT与B超在妇科盆腔肿瘤诊断中的临床价值。方法选取2010年6月～2013年5月收治的122例经手术和病理确诊的盆腔肿瘤患者,对其临床资料进行分析。结果 122例患者经手术病理证实其中子宫肌瘤48例,子宫颈癌30例,子宫内膜癌14例,子宫肉瘤8例,卵巢良性肿瘤16例,卵巢癌6例;CT的综合检出率为87.7%,B超的综合检出率为89.3%,两者之间综合检出率比较差异并无统计学意义（P〉0.05）。不同类型的妇科盆腔肿瘤比较差异无统计学意义（P〉0.05）。从单向结果分析,CT与B超在卵巢癌的检出率均达到了100%,检出效果最好。子宫内膜癌的检出率最低,其中CT检出率为85.7%,B超检出率为78.6%。结论 CT与B超在妇科盆腔肿瘤的诊断中均有较好的临床价值,在临床中可将B超作为诊断盆腔肿瘤的首选方法,而CT可作为其补充方法,具体应用策略应结合患者实际状况加以选择。

Comparison of application value of CT and B Ultrasound in diagnosis of gynecological pelvic tumors

Objective To analyze the clinical value of CT and B ultrasound in the diagnosis of gynecologic pelvic tumors. Methods 122 patients diagnosed with pelvic tumors by surgery and pathology that were treated from June 2010 to May 2013 were selected and their clinical data were analyzed. Results Of the 122 patients, surgery and pathology confirmed 48 patients with uterine fibroid, 30 patients with cervical cancer, 14 patients with endometrial cancer, 8 patients with uterine sarcoma, 16 patients with benign ovarian tumor and 6 patients with ovarian cancer. The comprehensive detection rate of CT was 87.7% and that of B ultrasound was 89.3%, with no statistically significant difference between the two methods（P〈0.05）. Different types of gynecological pelvic tumors did not have statistically significant differences（P〈0.05）. One-way results showed that the detection rates for ovarian cancer of both CT and B ultrasound reached 100%, showing the best detection effects. The detection rates for endometrial cancer were the lowest, of which the CT detection rate was 85.7% and the B ultrasound detection rate was 78.6%. Conclusion Both CT and B ultrasound have good clinical value in the diagnosis of gynecologic pelvic tumors. In clinical practice, B ultrasound can serve as the first choice for the diagnosis of gynecologic pelvic tumors and CT can serve as its supplementary method. Specific application measures should be chosen based on the patients＇ practical status.